3-氟苄脒盐酸盐 | 75207-72-6

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氟苄脒盐酸盐
• 中文别名: 3-氟苯甲脒盐酸盐；间氟甲基苯脒盐酸盐
• 英文名称: m-fluorobenzamidinium chloride
• 英文别名: (3-fluorobenzenecarboximidoyl) ammonium chloride；3-fluorobenzene-1-carboximidamide hydrogen chloride；3-fluorobenzene-1-carboximidamide hydrochloride；3-fluorobenzenecarboximidamide hydrochloride；3-fluorobenzimidamide hydrochloride；3-fluorobenzamidine hydrochloride；[Amino-(3-fluorophenyl)methylidene]azanium;chloride；[amino-(3-fluorophenyl)methylidene]azanium;chloride
• CAS: 75207-72-6
• 化学式: C₇H₇FN₂*ClH
• mdl: MFCD04114433
• 分子量: 174.605
• InChiKey: KISQHILAOJSVET-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.04
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  49.9
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 海关编码：
  2925290090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Fluorobenzamidine, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Fluorobenzamidine, HCl
CAS number: 75207-72-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7FN2.ClH
Molecular weight: 174.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氟苄脒盐酸盐 在 ammonium hydroxide 、 dimethyl sulfide borane 、 sodium 、 三溴化硼 、 potassium carbonate 、 三乙胺 、 三氯氧磷 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 二氯甲烷 为溶剂， 反应 145.0h， 生成 tert-butyl 4-(2-(3-fluorophenyl)-8-(pyridin-4-ylcarbamoyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-yl)piperazine-1-carboxylate
  参考文献：
  名称：

  [EN] BICYCLIC PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS
  [FR] PYRIDINES BICYCLIQUES ET ANALOGUES EN TANT QUE MODULATEURS DE LA SIRTUINE

  摘要：

  本文提供了新颖的调节sirtuin的化合物及其使用方法。这些调节sirtuin的化合物可用于延长细胞寿命，并治疗和/或预防各种疾病和紊乱，包括与老化或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块紊乱、炎症、癌症和/或潮红有关的疾病或紊乱，以及那些受益于增加线粒体活性的疾病或紊乱。还提供了包含调节sirtuin化合物与另一治疗剂组合的组合物。

  公开号：

  WO2011059839A1
• 作为产物：
  描述：

  3-氟苯腈 在 盐酸 、 氨 作用下， 以 乙醚 、 乙醇 为溶剂， 反应 96.0h， 生成 3-氟苄脒盐酸盐
  参考文献：
  名称：

  制备三唑并[1,5-c]嘧啶类药物作为潜在的抗哮喘药。

  摘要：

  通过使用人类嗜碱性粒细胞组胺释放测定法，发现5-芳基-2-氨基[1,2,4]三唑并[1,5-c]嘧啶具有作为介质释放抑制剂的活性。这些化合物是通过使芳酰胺与甲酰乙酸乙酯或丙酸乙酯反应生成嘧啶酮而制备的。用三氯氧磷处理得到氯嘧啶，然后用肼将其转化为肼基嘧啶。在Dimroth重排后，使用溴化氰进行环化，得到三唑并[1,5-c]嘧啶。在进行结构活性评估后，将5- [3-（三氟甲基）苯基] -2-氨基（8-10），5-（3-溴苯基）-2-氨基（8-13），5- [3-发现（二氟甲氧基）-苯基] -2-氨基（8-11）和5-（4-吡啶基）-2-氨基（6-7）化合物具有最佳活性。他们被选择进行进一步的药理和毒理学研究。

  DOI：

  10.1021/jm00166a023

文献信息

• Copper-Catalyzed Oxidative C(sp³)–H Functionalization for Facile Synthesis of 1,2,4-Triazoles and 1,3,5-Triazines from Amidines
  作者：Huawen Huang、Wei Guo、Wanqing Wu、Chao-Jun Li、Huanfeng Jiang

  DOI：10.1021/acs.orglett.5b00995

  日期：2015.6.19

  facile and versatile catalytic system involving copper catalyst, K3PO4 as the base, and O2 as the oxidant has been developed to enable efficient synthesis of 2,4,6-trisubstituted and 2,6-disubstituted 1,3,5-triazines and 1,3-disubstituted 1,2,4-triazoles from amidines with trialkylamines, DMSO, and DMF as the reaction partners, respectively. This protocol features inexpensive metal catalyst, green oxidant

  已经开发了一种简便而通用的催化体系，该体系涉及铜催化剂，K 3 PO 4为碱和O 2为氧化剂，以实现2,4,6-三取代和2,6-二取代的1,3,5的高效合成。 tri与三烷基胺，DMSO和DMF分别作为反应伙伴时，由am生成的-三嗪和1,3-二取代的1,2,4-三唑。该协议具有廉价的金属催化剂，绿色氧化剂，良好的官能团耐受性和高区域选择性的特点，可有效进入那些用传统方法难以制备的产品。提出了用于这些转化的单电子转移（SET）机制。
• Carbon Atom Insertion into Pyrroles and Indoles Promoted by Chlorodiazirines
  作者：Balu D. Dherange、Patrick Q. Kelly、Jordan P. Liles、Matthew S. Sigman、Mark D. Levin

  DOI：10.1021/jacs.1c06287

  日期：2021.8.4

  calculations supporting a selectivity-determining cyclopropanation step. Computations surprisingly indicate that the stereochemistry of cyclopropanation is of little consequence to the subsequent electrocyclic ring opening that forges the pyridine core, due to a compensatory homoaromatic stabilization that counterbalances orbital-controlled torquoselectivity effects. The utility of this skeletal transform is

  在这里，我们报告了一种反应，该反应通过将芳基羰基阳离子等价物分别插入吡咯和吲哚核心选择性地产生 3-芳基吡啶和喹啉基序。通过使用 α-chlorodiazirines 作为相应氯卡宾的热前体，可以修改作为母体 Ciamician-Denstedt 重排核心的传统基于卤仿的协议，以直接提供 3-（杂）芳基吡啶和喹啉。通过氧化可商购的脒鎓盐可方便地在一个步骤中制备氯二氮嗪。检测了作为吡咯取代模式函数的选择性，并提出了基于空间效应的预测模型，DFT 计算支持确定选择性的环丙烷化步骤。计算出人意料地表明，环丙烷化的立体化学对随后形成吡啶核心的电环开环几乎没有影响，这是由于补偿性同芳族稳定化抵消了轨道控制的扭矩选择性效应。通过喹啉的制备和药学相关吡咯的骨架编辑进一步证明了这种骨架转化的效用。
• DPP IV inhibitors
  申请人：——

  公开号：US20030130281A1

  公开（公告）日：2003-07-10

  The present invention relates to compounds of formula (I) 1 wherein R 1 , R 2 , and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

  本发明涉及以下式（I）的化合物： 其中R1、R2和X如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与DPP IV相关的疾病，如糖尿病，特别是非胰岛素依赖型糖尿病和糖耐量受损。
• [EN] PYRAZOLOTRIAZINES<br/>[FR] PYRAZOLOTRIAZINES
  申请人：BAYER AG

  公开号：WO2021116178A1

  公开（公告）日：2021-06-17

  The present invention provides compounds of general formula (I), in which X, R1, R2 and R3 are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of hyperproliferative disorders such as cancer disorders, as a sole agent or in combination with other active ingredients.

  本发明提供了具有通用公式（I）的化合物，其中X，R1，R2和R3如本文所述和定义，制备所述化合物的方法，用于制备所述化合物的有用中间化合物，包含所述化合物的药物组合物和组合，以及使用所述化合物用于制造用于治疗和/或预防疾病的药物组合物，特别是作为单一剂或与其他活性成分结合使用的过度增殖障碍，如癌症疾病。
• Base‐Mediated Decarboxylative [3+2] Annulation of Ethynyl Benzoxazinanones and Benzimidamides: Synthesis of Imidazole Derivatives
  作者：Lan Wang、Feng Jiang、Xing Gao、Wei Wang、Yongjun Wu、Hongchao Guo、Bing Zheng

  DOI：10.1002/adsc.202001550

  日期：2021.4.13

  A base‐mediated decarboxylative [3+2] annulation of trimethylsilylethynyl benzoxazinanones and benzimidamides hydrochloride was achieved under mild reaction conditions to give various imidazole derivatives in high yields. Notably, it demonstrated a new reaction mode of alkynyl benzoxazinanones.

  在温和的反应条件下，实现了碱介导的三甲基甲硅烷基乙炔基苯并恶嗪酮与盐酸苯并咪酰胺类化合物的[3 + 2]环化反应，以高收率得到了各种咪唑衍生物。值得注意的是，它展示了炔基苯并恶嗪酮的新反应模式。